A multinational drugmaker is paying 45 states including South Dakota $105 million to settle complaints that the company unlawfully marketed three drugs.
South Dakota Attorney General Marty Jackley says South Dakota's share of the settlement is nearly $1.2 million.
The settlement resolves allegations that London-based Glaxo illegally marketed Advair, Paxil and Wellbutrin for purposes that had not been approved by the Food and Drug Administration. Once the FDA approves a drug as safe and effective, a manufacturer cannot market or promote that drug for an unapproved use, a practice called off-label marketing.
The asthma treatment Advair is Glaxo's best-selling product. Paxil and Wellbutrin are antidepressant drugs.
Most Popular Today
Former School For The Deaf Campus Has New Buyer
- 2.Flooding, General
Sioux Falls Businesses Flooded
Casino Going In To 85th And Louise Strip Mall
CenturyLink Bringing Broadband to 15,000 Rural SD Households
- 5. All Industries
Businesses Urged To Sell Goods In Foreign Currency
Shop Dog Launches Line Of All-Natural Treats
- 7.Your Money Matters
New Buyer For Historic Sioux Falls Campus
SDN CEO To Testify Before Congress On Cybersecurity Threats
Business People Talk About How Technology Is Changing Their Work
Friday Morning Business Brief